These Were the Worst-Performing Stocks on the TSX Last Week

Markets keep rising, but there are bargains to be had. Learn more about beaten-down stocks like Imperial Metals Corp (TSX:III), Zymeworks Inc (TSX:ZYME)(NYSE:ZYME), and Canopy Rivers Inc (TSX:RIV).

| More on:
Businessman looking at a red arrow crashing through the floor

Image source: Getty Images.

The S&P/TSX Composite Index posted a strong performance last week, rising nearly 2%. While the majority of TSX stocks rose alongside the index, some companies weren’t as lucky. The three stocks below each lost more than 10% in just five days. If you want to find bargains in a rising market, here are three attractive candidates.

Down and out

Last month, Imperial Metals (TSX:III) stock shed roughly 11%. The reasons are unclear. The latest news occurred several week ago, on August 15, when the company reported second-quarter earnings. Even back then, the news wasn’t monumental. Revenue came in at $22 million — a slight decline from last year. Quarterly GAAP EPS was -$0.08, but the loss wasn’t surprising, considering Imperial has failed to generate a gross profit in each of the last five quarters.

In total, the 11% down move appears entirely unwarranted. Imperial’s market cap is just $300 million and volumes are limited, so it’s not surprising to see shares move irrationally. Can you profit by purchasing beaten-down shares? I’d be cautious.

In 2002, Imperial divested its oil and gas assets to become a pure-play mining company. The company now owns several mining projects that produce everything from gold and silver to zinc and copper. But despite the fact that it literally mints gold, Imperial has shown a consistent ability to destroy shareholder capital. This isn’t uncommon in the mining industry.

Since 2004, shares have cumulatively lost around 20% of their value. While share price movement never tells the whole story, it’s telling that the company hasn’t been able to generate net positive shareholder wealth after 15 years of trying. I’d stay away from this one.

This is your chance

Zymeworks (TSX:ZYME)(NYSE:ZYME) is far from Imperial Metals. The company’s market cap exceeds $1 billion, volumes are ample, and management has proven an ability to create value for stockholders. Since its IPO in 2017, the stock price has doubled. After a multi-week winning streak, shares reversed last week, falling a bit more than 10%. Unlike Imperial, this actually looks like an attractive investment opportunity.

Zymeworks is a clinical-stage biotech company based out of Vancouver, British Columbia. It develops protein therapeutics to treat cancer, autoimmune, and inflammatory diseases. Critically, the company’s products are a result of its molecular modeling software that helps optimize protein structure. So, in a way, Zymeworks is more of a tech company than a pharma company.

After a slew of deals this year, the company has now amassed nine active partnerships that include more than $8 billion in potential milestone payments and royalties. If the company’s technology platform is a success, shares could have more than 800% in upside based on current deals alone. Long term, this could be a multi-bagger several times over. The latest dip is a rare opportunity to get in at a discounted price.

Cannabis slump

Canopy Rivers is another $300 million company that had a tough week. Shares fell around 10%. The only news last week was actually positive. Its portfolio company, Herbert Works, received an R&D license from Health Canada to develop branded cannabis-infused beverages. Canopy Rivers owns 23% of Herbert Works.

If the news was positive, why the dip? The marijuana industry has been a wild ride. One of the biggest lessons of cannabis investing is to expect unforeseen volatility. Especially with these small-caps, sudden and unexplained moves are common. If you want to bet on cannabis, take a look at some of the smaller companies in the industry that have drifted lower despite improving fundamentals.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Tech Stocks

A stock price graph showing declines
Tech Stocks

Why Tesla Stock Dived Over 8% Today

Here’s the key reason why TSLA stock is being hammered Monday, despite reporting record Q3 2022 car deliveries and production…

Read more »

Dividend Stocks

3 Expensive TSX Stocks I’d Buy if They Took a Dip

Three relatively expensive large-cap stocks are on my buy list if their prices dip in the next market correction.

Read more »

Wireless technology
Tech Stocks

Why BlackBerry (TSX:BB) Stock Plunged 18% in September

BB stock took a serious hit in September, making it more attractive from a valuation standpoint, yet the stock is…

Read more »

Man holding magnifying glass over a document
Tech Stocks

3 Top U.S. Stocks to Watch in October

Are you looking to add some growth to your portfolio? Here are three discounted U.S. tech stocks to put on…

Read more »

A data center engineer works on a laptop at a server farm.
Tech Stocks

Got $2,000? These 2 Growth Stocks Are Near Their 52-Week Lows

Are you planning to buy the dip? These two top TSX growth stocks are trading near their 52-week lows. Moreover,…

Read more »

Hand holding smart phone with online shop concept on screen
Tech Stocks

Is Now the Time to Buy Shopify Stock?

Shopify stock (TSX:SHOP)(NYSE:SHOP) hasn't hit these lows in years. So is it a great time to buy the dip, or…

Read more »

money cash dividends
Tech Stocks

Got $1,000? 3 Cheap Stocks to Buy Right Now

If you've got cash on the sidelines that you're looking to put to work, here are three cheap stocks that…

Read more »

question marks written reminders tickets
Tech Stocks

Nvidia Stock Is Down 60%: Should You Buy?

Nvidia (NASDAQ:NVDA) stock has slipped over 60% as short-term headwinds hurt its revenue. But a long-term view of the stock…

Read more »